BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yilmaz M, Celik U, Hascicek S. Radiation recall dermatitis with dabrafenib and trametinib: A case report. World J Clin Cases 2020; 8(3): 522-526 [PMID: 32110661 DOI: 10.12998/wjcc.v8.i3.522]
URL: https://www.wjgnet.com/2307-8960/full/v8/i3/522.htm
Number Citing Articles
1
Avik Mandal, Pritanjali Singh, Sarthak Tandon, Dharmendra Singh. “Radiation Recall Phenomenon” with Novel Cytotoxic Agents: An Emerging Trend in the Last DecadeIndian Journal of Medical and Paediatric Oncology 2021; 42(01): 028 doi: 10.1055/s-0041-1729729
2
Miroslav Důra. Skin toxicity of BRAF and MEK inhibitorsOnkologie 2021; 15(4): 169 doi: 10.36290/xon.2021.033
3
Paloma Gomes, Amanda Gomes de Menêses, Renata Cristina de Campos Pereira Silveira, Eliete Neves Silva Guerra, Paula Elaine Diniz dos Reis, Elaine Barros Ferreira. Radiation recall dermatitis in cancer patients previously undergoing radiotherapy: a scoping reviewSupportive Care in Cancer 2026; 34(1) doi: 10.1007/s00520-025-10222-4
4
Dabrafenib/trametinibReactions Weekly 2020; 1796(1): 91 doi: 10.1007/s40278-020-76378-7
5
Elizabeth Guimond, Chiaojung Jillian Tsai, Ali Hosni, Grainne O'Kane, Jonathan Yang, Aisling Barry. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted TherapiesAdvances in Radiation Oncology 2022; 7(6): 101022 doi: 10.1016/j.adro.2022.101022
6
Kirti Sharma, Bhupesh Parashar, A. Gabriella Wernicke. Cefadroxil-Induced Radiation Recall Dermatitis: A Case Report and Review of the LiteratureCureus 2025;  doi: 10.7759/cureus.88735
7
Abhishek Purkayastha, Neelam Sharma, Sachin Taneja, Virender Suhag, Nishant Lohia. Sociodemographic, clinical profile, and treatment characteristics of oncology patients developing radiation recall phenomenonTzu Chi Medical Journal 2022; 34(3): 337 doi: 10.4103/tcmj.tcmj_163_21